Casa
carti master plus

Capecitabine, DNA/RNA Synthesis Inhibitor

Por um escritor misterioso

Descrição
Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.
Capecitabine, DNA/RNA Synthesis Inhibitor
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug
Capecitabine, DNA/RNA Synthesis Inhibitor
Metabolic conversion of capecitabine to 5-fluorouracil
Capecitabine, DNA/RNA Synthesis Inhibitor
Capecitabine, DNA, RNA and Protein Synthesis Inhibitors
Capecitabine, DNA/RNA Synthesis Inhibitor
Structures and mode of action of antimetabolites and DHFR inhibitors.
Capecitabine, DNA/RNA Synthesis Inhibitor
Nucleoside analogues and nucleobases in cancer treatment - The Lancet Oncology
Capecitabine, DNA/RNA Synthesis Inhibitor
Mechanism of thymidylate synthase inhibition by
Capecitabine, DNA/RNA Synthesis Inhibitor
Fluoropyrimidine-induced toxicity and DPD deficiency.. A case report of early onset, lethal capecitabine-induced toxicity and mini review of the literature. Uridine triacetate: Efficacy and safety as an antidote. Is it accessible outside
Capecitabine, DNA/RNA Synthesis Inhibitor
Frontiers Co-delivery of Cisplatin(IV) and Capecitabine as an Effective and Non-toxic Cancer Treatment
Capecitabine, DNA/RNA Synthesis Inhibitor
APExBIO - Capecitabine
Capecitabine, DNA/RNA Synthesis Inhibitor
Tysinor 150 Mg Capecitabine USP
Capecitabine, DNA/RNA Synthesis Inhibitor
Biomedicines, Free Full-Text
Capecitabine, DNA/RNA Synthesis Inhibitor
Mapping combinatorial drug effects to DNA damage response kinase inhibitors
Capecitabine, DNA/RNA Synthesis Inhibitor
A simplified map of 5-fluorouracil and capecitabine metabolism and
Capecitabine, DNA/RNA Synthesis Inhibitor
5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review)
Capecitabine, DNA/RNA Synthesis Inhibitor
Capecitabine, C15H22FN3O6
de por adulto (o preço varia de acordo com o tamanho do grupo)